Oramed Pharmaceuticals, Inc. (ORMP)
4.74
+0.07
(+1.50%)
USD |
NASDAQ |
Sep 18, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Free Cash Flow : -5.820M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.820M |
| March 31, 2026 | -9.107M |
| December 31, 2025 | -9.709M |
| September 30, 2025 | -11.02M |
| June 30, 2025 | -16.11M |
| March 31, 2025 | -10.47M |
| December 31, 2024 | -8.424M |
| September 30, 2024 | -7.821M |
| June 30, 2024 | -1.319M |
| March 31, 2024 | -5.909M |
| December 31, 2023 | -10.18M |
| September 30, 2023 | -16.76M |
| June 30, 2023 | -18.43M |
| March 31, 2023 | -24.01M |
| December 31, 2022 | -28.11M |
| September 30, 2022 | -26.50M |
| June 30, 2022 | -29.83M |
| March 31, 2022 | -25.24M |
| August 31, 2021 | -21.85M |
| May 31, 2021 | -18.44M |
| February 28, 2021 | -16.03M |
| November 30, 2020 | -16.20M |
| August 31, 2020 | -12.74M |
| May 31, 2020 | -13.25M |
| February 29, 2020 | -13.91M |
| Date | Value |
|---|---|
| November 30, 2019 | -12.08M |
| August 31, 2019 | -13.22M |
| May 31, 2019 | -14.46M |
| February 28, 2019 | -14.45M |
| November 30, 2018 | -16.07M |
| August 31, 2018 | -14.66M |
| May 31, 2018 | -12.06M |
| February 28, 2018 | -10.62M |
| November 30, 2017 | -10.06M |
| August 31, 2017 | -5.838M |
| May 31, 2017 | 3.015M |
| February 28, 2017 | 3.142M |
| November 30, 2016 | 8.393M |
| August 31, 2016 | 4.646M |
| May 31, 2016 | -3.185M |
| February 29, 2016 | -1.867M |
| November 30, 2015 | -5.795M |
| August 31, 2015 | -4.947M |
| May 31, 2015 | -4.723M |
| February 28, 2015 | -4.847M |
| November 30, 2014 | -4.729M |
| August 31, 2014 | -4.082M |
| May 31, 2014 | -3.671M |
| February 28, 2014 | -3.687M |
| November 30, 2013 | -3.473M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 13.56B |
| Pfizer Inc. | 10.99B |
| Liquidia Corp. | 150.69M |
| Scilex Holding Co. | -61.82M |
| BioAge Labs, Inc. | -88.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.2799M |
| Cash from Investing (Quarterly) | 3.920M |
| Cash from Financing (Quarterly) | -2.265M |
| Free Cash Flow Per Share (Quarterly) | -0.0066 |
| Free Cash Flow to Equity (Quarterly) | -0.2541M |
| Free Cash Flow to Firm (Quarterly) | -0.2821M |
| Free Cash Flow Yield | -2.93% |